HOLLIS MISIEWICZ: Open Payments
NPI 1326027731 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$193 in 7 payments from 5 companies in 2025. Trend: 2023 $234 · 2024 $103 · 2025 $193
Food & beverage: $193
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $74 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $46 |
| Regeneron Healthcare Solutions, Inc. | 1 | $30 |
| ABBVIE INC. | 1 | $23 |
| GENZYME CORPORATION | 1 | $19 |
Products named: FRUZAQLA, Nubeqa, LIBTAYO, ICLUSIG, IMBRUVICA, SARCLISA.
Industry payments across MD — which companies pay providers there.
